×
About 4,917 results

ALLMedicine™ Thyroglobulin Center

Research & Reviews  2,429 results

PET/CT in the management of differentiated thyroid cancer.
https://doi.org/10.1016/j.diii.2021.04.004
Diagnostic and Interventional Imaging; Zampella E, Klain M et. al.

Apr 30th, 2021 - The standard treatment of differentiated thyroid cancer (DTC) consists of surgery followed by iodine-131 (131I) administration. Although the majority of DTC has a very good prognosis, more aggressive histologic subtypes convey a worse prognosis. F...

Prostate-Specific Membrane Antigen Expression in Patients With Differentiated Thyroid C...
https://doi.org/10.1097/RLU.0000000000003655
Clinical Nuclear Medicine; Verma P, Malhotra G et. al.

Apr 22nd, 2021 - Prostate-specific membrane antigen (PSMA) is a member of superfamily of zinc-dependent exopeptidases that is robustly expressed in prostate cancer cells and nonprostatic solid tumor neovasculature including microvessels of thyroid tumors. Its expr...

The value of serum thyroglobuline alteration after ultrasonography-guided fine-needle b...
https://doi.org/10.1111/ijcp.14218
International Journal of Clinical Practice; Dellal Kahramanca FD, Aydin C et. al.

Apr 18th, 2021 - It is known that serum thyroglobulin (TG) can increase after fine-needle biopsy of thyroid nodules.We aimed to determine whether TG is increased after ultrasonography guided fine needle capillary biopsy (FNC) of suspicious cervical LNs in thyroide...

Resolution of hyperthyroidism and thyroid antibodies following struma ovarii resection:...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054055
BMJ Case Reports; Padmanaban P, Nylen E et. al.

Apr 16th, 2021 - We report a case of 34-year-old clinically asymptomatic woman who had been followed for 6 years for hyperthyroidism with thyroid stimulating hormone <0.006 uIU/mL, free T4 1.98 ng/mL, free T3 5.3 pg/mL, elevated thyroid stimulating immunoglobulin ...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  2,455 results

PET/CT in the management of differentiated thyroid cancer.
https://doi.org/10.1016/j.diii.2021.04.004
Diagnostic and Interventional Imaging; Zampella E, Klain M et. al.

Apr 30th, 2021 - The standard treatment of differentiated thyroid cancer (DTC) consists of surgery followed by iodine-131 (131I) administration. Although the majority of DTC has a very good prognosis, more aggressive histologic subtypes convey a worse prognosis. F...

Prostate-Specific Membrane Antigen Expression in Patients With Differentiated Thyroid C...
https://doi.org/10.1097/RLU.0000000000003655
Clinical Nuclear Medicine; Verma P, Malhotra G et. al.

Apr 22nd, 2021 - Prostate-specific membrane antigen (PSMA) is a member of superfamily of zinc-dependent exopeptidases that is robustly expressed in prostate cancer cells and nonprostatic solid tumor neovasculature including microvessels of thyroid tumors. Its expr...

The value of serum thyroglobuline alteration after ultrasonography-guided fine-needle b...
https://doi.org/10.1111/ijcp.14218
International Journal of Clinical Practice; Dellal Kahramanca FD, Aydin C et. al.

Apr 18th, 2021 - It is known that serum thyroglobulin (TG) can increase after fine-needle biopsy of thyroid nodules.We aimed to determine whether TG is increased after ultrasonography guided fine needle capillary biopsy (FNC) of suspicious cervical LNs in thyroide...

Resolution of hyperthyroidism and thyroid antibodies following struma ovarii resection:...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054055
BMJ Case Reports; Padmanaban P, Nylen E et. al.

Apr 16th, 2021 - We report a case of 34-year-old clinically asymptomatic woman who had been followed for 6 years for hyperthyroidism with thyroid stimulating hormone <0.006 uIU/mL, free T4 1.98 ng/mL, free T3 5.3 pg/mL, elevated thyroid stimulating immunoglobulin ...

see more →

News  31 results

Subclinical Hypothyroidism Balancing Act: Knowing When to Treat
https://www.staging.medscape.com/viewarticle/919024_4

Oct 2nd, 2019 - Question: What should you do next? Your Peers Chose: Start levothyroxine 0% Repeat TSH test in 2-3 months and check TPO antibody level 0% Reassure the patient that no treatment is needed; repeat TSH test in 1 year 0% Check thyroglobulin and thyrog...

When it comes to thyroid cancer follow-up, serum microRNA profiles have earned new respect
https://www.mdedge.com/familymedicine/article/161165/pituitary-thyroid-adrenal-disorders/when-it-comes-thyroid-cancer/page/0/1
Clinical Endocrinology News;

Mar 18th, 2018 - Serum levels of both miRNAs after 1 to 2 years of follow-up were consistent with ATA responses to therapy in all patients, including two patients who developed structural evidence of disease whose thyroglobulin assay results remained negative (les.

Thyroid-nodule size boosts serum thyroglobulin’s diagnostic value
https://www.mdedge.com/familymedicine/article/143633/pituitary-thyroid-adrenal-disorders/thyroid-nodule-size-boosts-serum
Clinical Endocrinology News; Mitchel L. Zoler

Jul 31st, 2017 - BOSTON – Normalizing the serum thyroglobulin level by thyroid nodule size in patients surgically treated for a thyroid nodule produced a strongly significant link between the level of this marker and nodule malignancy in a review of nearly 200 pat.

Thyroid Cancer: Incidence on the Rise
https://www.mdedge.com/clinicianreviews/article/114971/endocrinology/thyroid-cancer-incidence-rise/page/0/3

Oct 11th, 2016 - LONG-TERM PATIENT MANAGEMENT After thyroidectomy and radioactive iodine treatment, follicular cell cancers (eg, papillary, follicular, anaplastic) are managed by following patients’ thyroid-stimulating hormone (TSH), thyroglobulin, and antithyrogl.

Thyroglobulin can’t predict pazopanib response in differentiated thyroid cancer
https://www.mdedge.com/internalmedicine/article/103709/head-neck-cancers/thyroglobulin-cant-predict-pazopanib-response
Michele G. Sullivan

Oct 21st, 2015 - Lake BUENA VISTA, FLA. – Pazopanib is an effective therapy for advanced thyroid cancer, but at present, there seems to be no way to predict which patients will respond to it.

see more →